GLP-1 Medicines for PCOS: Weight Management, PMOS and Fertility Questions

People searching for GLP-1 treatment for PCOS often want help with several concerns at once: weight, insulin resistance, irregular periods and future pregnancy. Those concerns deserve a coordinated discussion. They should not be reduced to an online promise that one prescription will fix every aspect of the condition.

This guide separates the role of weight-management medication from fertility care and explains what to ask before joining a program. A clinician who knows your history should determine whether a particular medicine fits your goals.

Why you may now see PMOS instead of PCOS

Monash University announced the name polyendocrine metabolic ovarian syndrome, or PMOS, in May 2026 for the condition previously called polycystic ovary syndrome. The change aims to better describe its broader hormonal and metabolic features¹.

You may still see PCOS on medical records, insurance forms and older research. Monash's guideline hub identifies the new name alongside the existing guideline resources². When speaking with a new clinician, use whichever term appears in your records and confirm that everyone is discussing the same established diagnosis. Renaming the condition does not automatically change your prescription or coverage.

Where GLP-1 medicines fit

The 2023 international guideline says anti-obesity medicines, including semaglutide and liraglutide, can be considered alongside lifestyle intervention for higher weight in adults with PCOS, following general-population guidance. It emphasizes shared decisions about side effects, longer-term use and weight regain after stopping³.

That recommendation is narrower than “GLP-1s treat PCOS.” Wegovy's U.S. label includes specified weight-management and other indications, but does not list PCOS or infertility as an approved indication⁴. A diagnosis alone should not be treated as automatic eligibility for any particular product.

Ask the prescriber to state the treatment indication clearly. Is the proposed plan for obesity, diabetes or another established indication? What outcome is being monitored? Those questions help distinguish a clinical rationale from marketing aimed at a familiar search term.

Define the outcome you want to improve

Bring your priorities to the appointment: perhaps managing diabetes risk, dealing with distressing symptoms, preserving recovery from disordered eating or planning pregnancy. Ask which goals the proposed medicine is intended to address and which require a separate plan.

For example, a change in weight does not by itself answer whether menstrual symptoms have been evaluated or whether you need fertility assessment. Ask how progress will be reviewed beyond the number on a scale. If several clinicians are involved, request a shared summary of the goals and who is responsible for each.

A useful written plan identifies the starting situation, the proposed intervention and the follow-up decision. “We'll see how you feel” is less helpful than knowing what the clinician will review at the next appointment and how to contact them sooner if needed.

Pregnancy plans belong in the first conversation

The international guideline advises effective contraception when pregnancy is possible during GLP-1 treatment because pregnancy safety data are lacking³. Do not interpret an irregular cycle as a contraception plan, or assume that a weight-management prescription is a fertility treatment.

For Wegovy, the current label specifies stopping at least two months before a planned pregnancy in the relevant circumstances because semaglutide remains in the body for a long time⁴. Your clinician should plan the timing and any alternative treatment. Do not apply one product's interval to every medicine or wait until a refill is due to raise the question.

Our pregnancy and fertility guide explains the wider discussion. If your plan includes tirzepatide or an oral contraceptive, also review the birth-control interaction guide with your prescriber. The interaction questions are medicine-specific.

Ask how existing care will be coordinated

Take a complete medication list, recent results and relevant gynecology or endocrinology records to the visit. Ask whether the proposed service can review those records and communicate with your usual clinician. Avoid enrolling in parallel programs without telling each prescriber what the other is doing.

The laboratory monitoring guide can help you ask what each proposed test will change. A broad panel is not a substitute for discussing symptoms and goals. If a new test is suggested, ask who interprets it, how the result reaches you and whether follow-up is included in the price.

Likewise, tell the clinician about eating-disorder history and current difficulty eating. The nutrition guide discusses general support questions; individualized care may require additional expertise. A program should explain its limits and referral arrangements instead of promising to manage every concern remotely.

Plan for tolerability and continuity

Ask who handles side effects between appointments and how the plan changes if you cannot tolerate treatment. Clarify what happens if insurance coverage changes or you want to try to conceive. Long-term planning is part of the decision, not an issue to leave until medication becomes unaffordable.

The guideline's discussion of potential longer-term use and regain after discontinuation makes continuity worth discussing from the beginning³. Our weight-regain guide explains that separate question. Ask for a follow-up plan that accounts for your personal reasons for changing or stopping treatment.

Compare program terms after clinical suitability

If your clinician agrees that weight-management medication is appropriate, compare access to appointments, records, nutrition support and the full ongoing cost. Ask specifically whether a service has the expertise your situation requires; a general weight-management offering does not establish specialist PCOS or fertility care.

The Found review and Sesame Care review describe different published service arrangements. The Found versus Sesame Care comparison puts their published terms side by side. Use the best-provider guides for broader cost and access questions, then confirm what the individual service can actually provide. Reviews and rankings cannot establish your eligibility or substitute for coordinated reproductive and metabolic care.